New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Why start mammograms at 40? Doctor explains new advice

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra
Oncology January 08,2024
Why start mammograms at 40? Doctor explains new advice

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra
Oncology January 08,2024
To stop spread of cancer, researchers target two signaling switches that trigger new blood vessel growth

To stop spread of cancer, researchers target two signaling switches that trigger new blood vessel growth

byUniversity of East AngliaCredit: Unsplash/CC0 Public DomainHitting two targets at the same time may be the key to stopping the spread of aggressive cancers, according to new research from the
Oncology January 08,2024
To stop spread of cancer, researchers target two signaling switches that trigger new blood vessel growth

To stop spread of cancer, researchers target two signaling switches that trigger new blood vessel growth

byUniversity of East AngliaCredit: Unsplash/CC0 Public DomainHitting two targets at the same time may be the key to stopping the spread of aggressive cancers, according to new research from the
Oncology January 08,2024
Interrupting endocrine therapy to pursue pregnancy doesn't lead to worse short-term breast cancer recurrence rates

Interrupting endocrine therapy to pursue pregnancy doesn't lead to worse short-term breast cancer recurrence rates

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBreast cancer patients who paused their endocrine therapy to try to get pregnant experienced short-term rates of breas
Oncology January 08,2024
Interrupting endocrine therapy to pursue pregnancy doesn't lead to worse short-term breast cancer recurrence rates

Interrupting endocrine therapy to pursue pregnancy doesn't lead to worse short-term breast cancer recurrence rates

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBreast cancer patients who paused their endocrine therapy to try to get pregnant experienced short-term rates of breas
Oncology January 08,2024
To improve a promising cancer drug, cut it in half

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur
Oncology January 08,2024
To improve a promising cancer drug, cut it in half

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur
Oncology January 08,2024
Study points to novel method for early diagnosis of cachexia in lung cancer patients

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o
Oncology January 08,2024
Study points to novel method for early diagnosis of cachexia in lung cancer patients

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o
Oncology January 08,2024
Tail spin: Study reveals new way to reduce friendly fire in cell therapy

Tail spin: Study reveals new way to reduce friendly fire in cell therapy

by Bill Hathaway,Yale UniversityIn CAR-T therapy, T cells in blue find antigens (red) and kill cancer cells (purple). But often, antigens attach to other T cells leading other T cells to attack
Oncology January 08,2024
Tail spin: Study reveals new way to reduce friendly fire in cell therapy

Tail spin: Study reveals new way to reduce friendly fire in cell therapy

by Bill Hathaway,Yale UniversityIn CAR-T therapy, T cells in blue find antigens (red) and kill cancer cells (purple). But often, antigens attach to other T cells leading other T cells to attack
Oncology January 08,2024
Great oaks grow from small acorns: Oncology is committed to doing its part for sustainability

Great oaks grow from small acorns: Oncology is committed to doing its part for sustainability

byEuropean Society for Medical OncologySustainability will be at the heart of many discussions at theESMO Congress 2022, as illustrated by the new results and initiatives spanning cancer p
Oncology January 08,2024
Great oaks grow from small acorns: Oncology is committed to doing its part for sustainability

Great oaks grow from small acorns: Oncology is committed to doing its part for sustainability

byEuropean Society for Medical OncologySustainability will be at the heart of many discussions at theESMO Congress 2022, as illustrated by the new results and initiatives spanning cancer p
Oncology January 08,2024
Vitamin C may hold the key to improve efficacy of dendritic cell-derived anticancer cell therapies

Vitamin C may hold the key to improve efficacy of dendritic cell-derived anticancer cell therapies

byJosep Carreras Leukaemia Research InstituteVitamin C-mediated dendritic cell DNA methylome remodeling. (A) Scheme depicting the experimental setup. Monocytes (MO) were differentiated to dendri
Oncology January 08,2024
Vitamin C may hold the key to improve efficacy of dendritic cell-derived anticancer cell therapies

Vitamin C may hold the key to improve efficacy of dendritic cell-derived anticancer cell therapies

byJosep Carreras Leukaemia Research InstituteVitamin C-mediated dendritic cell DNA methylome remodeling. (A) Scheme depicting the experimental setup. Monocytes (MO) were differentiated to dendri
Oncology January 08,2024
Tiny surgical robots could transform detection and treatment of cancers

Tiny surgical robots could transform detection and treatment of cancers

byUniversity of LeedsRobotic platform for peripheral lung tumor intervention based on magnetic tentacles. Credit: STORM Lab, University of LeedsA tiny robot which can travel deep into the lungs
Oncology January 08,2024
Tiny surgical robots could transform detection and treatment of cancers

Tiny surgical robots could transform detection and treatment of cancers

byUniversity of LeedsRobotic platform for peripheral lung tumor intervention based on magnetic tentacles. Credit: STORM Lab, University of LeedsA tiny robot which can travel deep into the lungs
Oncology January 08,2024
Tiny, implantable therapeutic sponge device helps kill cancer in mice

Tiny, implantable therapeutic sponge device helps kill cancer in mice

by Wayne Lewis,University of California, Los AngelesThe SymphNode device (left), contains nanoparticles (red dots) that release a drug that blocks the activity of regulatory T cells (green), whi
Oncology January 08,2024
Tiny, implantable therapeutic sponge device helps kill cancer in mice

Tiny, implantable therapeutic sponge device helps kill cancer in mice

by Wayne Lewis,University of California, Los AngelesThe SymphNode device (left), contains nanoparticles (red dots) that release a drug that blocks the activity of regulatory T cells (green), whi
Oncology January 08,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com